Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01813162 · ClinicalTrials.gov registry record · Phase 1
In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
A Phase 1 study of HIV Prevention, sponsored by CONRAD.
- Completed
- Registry status
- Phase 1
- Development phase
- 101
- Enrollment target
- 2
- Study locations
NCT01813162 is a Phase 1 study of HIV Prevention that has completed, run by CONRAD. The registered enrollment target is 101 participants, below the 379-participant average among 32 other HIV Prevention trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01813162, a Phase 1 study of HIV Prevention, has completed, sponsored by CONRAD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 101 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is determine if the local release characteristics and systemic exposure to tenofovir (TFV) 1% gel and a given commonly used vaginal product are impacted by concomitant use
Conditions Studied
Interventions
- DRUG Tenofovir 1% gel
- DRUG Vaginal product
Study Locations (2)
California
- Dept of OBGYN and Reproductive Sciences, UCSF - San Francisco
New York
- Bronx-Lebanon Hospital Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01813162
The ClinicalTrials.gov registry entry for NCT01813162 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 379-participant average among 32 other HIV Prevention trials with a reported enrollment target (73% lower). The listed sponsor is CONRAD, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Prevention appearing as the primary indexed condition, and to 2 interventions - of which Tenofovir 1% gel is the first listed.
NCT01813162 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, New York.
Frequently Asked Questions
What is clinical trial NCT01813162 about?
NCT01813162 is a clinical study titled "In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products". The purpose of the study is determine if the local release characteristics and systemic exposure to tenofovir (TFV) 1% gel and a given commonly used vaginal product are impacted by concomitant use
What is the current status of trial NCT01813162?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 101 participants. The study started on 2013-12. Estimated completion is 2014-12.
What conditions does trial NCT01813162 study?
This clinical trial studies the following conditions: HIV Prevention.
What interventions are being tested in trial NCT01813162?
The interventions under investigation include: Tenofovir 1% gel (DRUG), Vaginal product (DRUG).
Who is sponsoring clinical trial NCT01813162?
This trial is sponsored by CONRAD, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01813162 being conducted?
This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers
RECRUITING · Phase 1
-
An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations
COMPLETED · Phase 1
-
Using PrEP, Doing It for Ourselves
RECRUITING · NA
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
RECRUITING · NA
-
Intervention to Enhance PrEP Persistence
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.